Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Onexton

Generic name: Clindamycin phosphate and benzoyl peroxide

FDA application holder: Bausch

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Onexton?
Onexton is a brand name of Clindamycin phosphate and benzoyl peroxide, a prescription medicine. The FDA NDC Directory lists 1 Onexton product in 1 strength and form.
Who makes Onexton?
Bausch holds the FDA application for Onexton (NDA050819, approved October 23, 2008).
Is there a generic or store brand of Onexton?
Yes. The FDA NDC Directory lists 4 other products with the same active ingredients, strength and form as a Onexton product, 4 of them generic. Ask your pharmacist whether one is right for you.
Has Onexton been recalled?
No recall linked to Onexton products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Onexton is

Each Onexton product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Clindamycin phosphate and benzoyl peroxide · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
benzoyl peroxide 3.75% · clindamycin phosphate 1%
gel (topical)
Onexton 4 products, 4 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Clindamycin phosphate and benzoyl peroxide →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Onexton products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA050819BauschOctober 23, 20081

Companies that list Onexton

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Onexton products.

Recalls

No recall linked to Onexton products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers